Role of COP 9 signalosome subunit 5 in preserving immunoprivilege of allogeneic mesenchymal stem cells in the ischemic heart
Role of COP 9 signalosome subunit 5 in preserving immunoprivilege of allogeneic mesenchymal stem cells in the ischemic heart
批准号:
444561
负责人:
Dhingra Sanjiv
金额:
$69.94万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2021
资助国家:
加拿大
项目状态:
未结题
起止时间:
2021-04-01 至 2026-04-01
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Heart disease is one of the leading causes of death in Canada. Currently available treatments offer effective relief of symptoms but unfortunately cannot provide a permanent cure. Therefore, new research is needed to find a permanent solution for this dis
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Determinants of immunogenicity of allogeneic mesenchymal stem cells in the ischemic heart
-
批准号:478259
-
项目类别:Operating Grants
-
资助金额:$74.87万
-
财政年份:2023
-
负责人:Dhingra Sanjiv
-
依托单位:
Role of HSP90-alpha in preserving immunoprivilege of allogenic mesenchymal stem cells in the ischemic heart
-
批准号:370541
-
项目类别:Operating Grants
-
资助金额:$54.62万
-
财政年份:2017
-
负责人:Dhingra Sanjiv
-
依托单位:
Preserving the immunoprivilege of transplanted allogeneic mesenchymal stem cells in the ischemic heart
-
批准号:321665
-
项目类别:Operating Grants
-
资助金额:$37.97万
-
财政年份:2015
-
负责人:Dhingra Sanjiv
-
依托单位:
海外基金